Jan 20, 2022
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system (“CNS”), today announced that its CEO John Climaco will participate in the Virtual Investor 2022 Top Picks Conference at 11:00 a.m. ET on Wednesday, Jan. 26, 2022. As part of the virtual event, the company will provide a corporate presentation followed by an interactive Q&A session. In addition to the moderated portion, investors and attendees will have the opportunity to submit questions live during the event or in advance of the conference via www.VirtualInvestorCo.com. A live video webcast of the presentation will be available on the company’s website, with a webcast replay available two hours following the live presentation and accessible for one year.
To view the full press release, visit https://ibn.fm/sj81h
About CNS Pharmaceuticals Inc.
CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The company’s lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is currently in development for the treatment of a number of serious brain and CNS oncology indications including glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Additionally, the company is advancing the development of its WP1244 drug technology, which utilizes anthracycline and distamycin-based scaffolds to create small molecule agents and is believed to be 500x more potent than daunorubicin in inhibiting tumor cell proliferation. Preclinical studies of WP1244 demonstrated high uptake in the brain with antitumor activity. CNS Pharmaceuticals is evaluating the use of WP1244 in the treatment of brain cancers, pancreatic, ovarian, and lymphomas. For more information, visit the company’s website at www.CNSPharma.com.
NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at https://ibn.fm/CNSP
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
If you think a few tins of baked beans at the back of the cupboard are enough to see you through a disaster, experts say you're dangerously underprepared.
Read moreIf you've ever thought of sleepwalking as a harmless quirk, the case of 23-year-old Kenneth Parks will make you think again.
Read moreISRO's successful launch of NVS-03 aboard the GSLV-F18 rocket has restored India's NavIC navigation system to its minimum operational configuration of four satellites. Why is the mission crucial for India's strategic autonomy, and how could NavIC reduce dependence on foreign navigation systems?
Read moreAn art prodigy has revealed the vivid details of her visions of heaven, including the face of Jesus that has followed her for most of her life.
Read moreThe system that has driven life-altering discoveries and helped make the United States a superpower is now under intense strain.
Read moreSpaceX Falcon 9 reaches 700th launch with starlink satellites in historic featSpaceX has reached a major milestone with its 700th Falcon 9 launch deploying another batch of Starlink satellites into orbit. The mission underscores the rocket’s significant role in growing the company’s...
Read moreA Halloween-themed protest against fossil fuels has targeted the first minister's residence in Edinburgh.
Read moreWith US President Donald Trump recently pushing the use of “superintelligence” (SI) instead of artificial intelligence (AI) in national discourse, the acronym has gained unprecedented attention. It is the right acronym but the wrong meaning. In my opinion, SI should stand for “self-intelligence”. It probably explains why academics, critics and even major AI companies are calling for a temporary pause in AI development. They must have realised the technology’s current trajectory is headed down...
Read moreWhat happens after death remains one of humanity's greatest and most enduring mysteries.
Read moreAncient Mars was wetter than thought, meteorite study reveals A 4.1-billion-year-old meteorite found in 2022 in the Sahara desert, approximately from the village of Bir Chali has a surprising yet previously unknown story to tell about the past of Mars. Speaking about the features of the rock, it...
Read moreAmerican blockchain analysis firm Chainalysis said it was the target of a cybersecurity incident in which an external actor accessed non-sensitive customer data. However, the company noted that the breach did not result in unauthorized access to its investigation content, authentication credentials, or session tokens. "This month, Chainalysis detected an external actor using offensive agentic
Read moreApple’s long-awaited artificial intelligence features will be officially launched in China in December, ending two years of regulatory uncertainty as the US tech giant seeks to bring advanced technologies to its second-largest market with the help of Alibaba Group Holding. The first batch of Apple Intelligence services will roll out to Chinese iPhone users alongside the iOS 27.3 update in December, following an open beta test with developers starting November 4, the US company said in a...
Read moreYOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.
